checkAd
    Startseite > Aktien > Sutro Biopharma > Nachrichten
    Sutro Biopharma
    Aktie
    ISIN: US8693671021 WKN: A2N6SG SYM: STRO Land USA
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    3,4600
     
    USD
    -10,13 %
    -0,3900 USD
    Letzter Kurs 15.06.24 Nasdaq
    Geldkurs
    14.06.24
    3,4600
     
    USD
    9.300 STK
    Briefkurs
    14.06.24
    3,4700
     
    USD
    1.000 STK

    Sutro Biopharma Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
    13.05.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Announces Initiation of Randomized Portion (Part 2) of REFRαME-O1 Trial
    30.04.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
    02.04.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
    25.03.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma to Participate in Upcoming Investor Conferences
    06.02.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC
    04.01.24 · globenewswire · Sutro Biopharma
    Sutro Biopharma to Host Investor Webcast Highlighting Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeted ADC, on January 4, 2024
    14.12.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer
    21.11.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
    13.11.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Announces Presentation of Data for Luveltamab Tazevibulin (luvelta) from the Phase 1 Dose-Expansion Study in Endometrial Cancers at ESMO 2023
    22.10.23 · globenewswire · Sutro Biopharma
    Sutro Demonstrates Meaningful ADC Innovation with Five Presentations and One Poster at the 14th Annual World ADC Conference
    16.10.23 · globenewswire · Sutro Biopharma
    Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer
    19.09.23 · globenewswire · Sutro Biopharma